Evaluation of the Adequacy of Levothyroxine Replacement Therapy in Patients with Central Hypothyroidism1
The DOI matches its Crossref record; 33 of the 34 references it cites were found in a registry or an index.
Abstract
As there are few data on the evaluation of the adequacy of levothyroxine (l-T4) therapy in patients with central hypothyroidism (CH), a prospective study was performed to assess the accuracy of various parameters in the follow-up of 37 CH patients. Total and free thyroid hormones, TSH, and a series of clinical and biochemical indexes of peripheral thyroid hormone action have been evaluated off and on l-T4 therapy. Samples were taken before the daily administration of l-T4. In all patients off therapy, clinical hypothyroidism and low levels of free T4 (FT4) were observed, whereas values of FT3, total T4, and total T3 were below the normal range in 73%, 57%, and 19% of cases, respectively. Most of the indexes of thyroid hormone action were significantly modified after l-T4 withdrawal and exhibited significant correlation with free thyroid hormone levels. During l-T4 replacement therapy, 32 patients had circulating levels of FT4 and FT3 and indexes within the normal range with a mean l-T4 daily dose of 1.5 ± 0.3 μg/kg BW. Despite normal serum FT4, 3 patients had borderline high values of FT3 and a clear elevation of serum-soluble interleukin-2 receptor concentrations, suggesting overtreatment. Low or borderline low FT4/FT3 levels indicated undertreatment in 2 patients. The clinical parameters lack the required specificity for the diagnosis or follow-up of CH patients. The l-T4 daily dose should be established, taking into account the weight, the age, and the presence of other hormone deficiencies or pharmacological treatment of CH patients. In conclusion, our results indicate that the diagnosis of CH is reached at best by measuring TSH and FT4 concentrations. In the evaluation of the adequacy of l-T4 replacement therapy, both FT4 and FT3 serum levels together with some biochemical indexes of thyroid hormone action are all necessary to a more accurate disclosure of over- or undertreated patients.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Manifestations of CeH are similar to those of primary hypothyroidism, but they can be masked by coexistent MPHD [1, 24, 25].”
From 2018 European Thyroid Association (ETA) Guidelines on the Diagnosis and Management of Central Hypothyroidism (2018) · cites this paper as [24]
In the citing paper
“As in primary hypothyroidism [53], younger CeH patients require higher doses than the older ones [24, 25].”
From 2018 European Thyroid Association (ETA) Guidelines on the Diagnosis and Management of Central Hypothyroidism (2018) · cites this paper as [24]
In the citing paper
“Overt CeH is most frequently indicated by the combined findings of low FT4 with low or normal TSH concentrations [24, 25].”
From 2018 European Thyroid Association (ETA) Guidelines on the Diagnosis and Management of Central Hypothyroidism (2018) · cites this paper as [24]
In the citing paper
“Indeed, mean L-T4 daily doses of 1.2-1.6 μg/kg bw/day were judged sufficient in the large majority of adult CeH patients, with the main aim of achieving a more appropriate metabolic profile [24, 25, 55].”
From 2018 European Thyroid Association (ETA) Guidelines on the Diagnosis and Management of Central Hypothyroidism (2018) · cites this paper as [24]
In the citing paper
“In particular, serum TSH concentrations are rapidly suppressed in a large portion of CeH patients during the administration of L-T4 [24, 25].”
From 2018 European Thyroid Association (ETA) Guidelines on the Diagnosis and Management of Central Hypothyroidism (2018) · cites this paper as [24]
3 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Mutations in PROP1 cause familial combined pituitary hormone deficiency
Wu, W., Cogan, J. D., Pfäffle, R. W., Dasen, J. S., Frisch, H., O'Connell, S. M., Flynn, S. E., Brown, M. R., Mullis, P. E., Parks, J. S., et al. (1998) · Nature Genetics · doi:10.1038/ng0298-147 · Cited by 568
Thyrotropin-Secreting Pituitary Tumors*
BECK-PECCOZ, P., BRUCKER-DAVIS, F., PERSANI, L., SMALLRIDGE, R. C., & WEINTRAUB, B. D. (1996) · Endocrine Reviews · doi:10.1210/edrv-17-6-610 · Cited by 491
Self-citationEffects of thyroid hormones on bone and mineral metabolism
Mosekilde, L., Eriksen, E. F., & Charles, P. (1990) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(18)30338-4 · Cited by 423
Levothyroxine Therapy in Patients with Thyroid Disease
Mandel, S. J., Brent, G. A., & Larsen, P. R. (1993) · Annals of Internal Medicine · doi:10.7326/0003-4819-119-6-199309150-00009 · Cited by 324
Beck-Peccoz, P., Amr, S., Menezes-Ferreira, M. M., Faglia, G., & Weintraub, B. D. (1985) · New England Journal of Medicine · doi:10.1056/nejm198504253121703 · Cited by 261 · cited 1×
“Restoration and maintenance of euthyroidism represent the therapeutic goals in CH. Specific therapies, such as oral TRH administration have been abandoned because of their cost and their restricted applicability to few patients with hypothalamic hypothyroidism ( 9 , 10).”
BackgroundSelf-citationThe Variable Clinical Phenotype in Thyroid Hormone Resistance Syndrome
BECK-PECCOZ, P., & CHATTERJEE, V. K. K. (1994) · Thyroid · doi:10.1089/thy.1994.4.225 · Cited by 231
Self-citationZelissen, P. M. J., Croughs, R. J. M., van Rijk, P. P., & Raymakers, J. A. (1994) · Annals of Internal Medicine · doi:10.7326/0003-4819-120-3-199402010-00005 · Cited by 225
Collu, R., Tang, J., Castagné, J., Lagacé, G., Masson, N., Huot, C., Deal, C., Delvin, E., Faccenda, E., Eidne, K. A., et al. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.5.3918 · Cited by 207
Wood, A. J. J., & Toft, A. D. (1994) · New England Journal of Medicine · doi:10.1056/nejm199407213310307 · Cited by 172
Hayashizaki, Y., Hiraoka, Y., Endo, Y., Miyai, K., & Matsubara, K. (1989) · The EMBO Journal · doi:10.1002/j.1460-2075.1989.tb08355.x · Cited by 152
Research works printed but not linked: 5
- Collu, J Clin Endocrinol Metab, 82, 1561
- Beck-Peccoz, 1988, Congenital thyroid disease., In: Bailliere Clin Endocrinol Metab, 2, 737
- Mariotti, 1992, Thyroid function and thyroid autoimmunity indipendently modulate serum concentration of soluble interleukin 2 (IL2) receptor (sIL2R) in thyroid diseases., Clin Endocrinol (Oxf), 37, 417
- Pazos, J Clin Endocrinol Metab, 80, 562
- 1988, Osteoporosis: a growing concern for the thyroidologist., Thyroid Today, 11, 1
Cited by
Jonklaas, J., Bianco, A. C., Bauer, A. J., Burman, K. D., Cappola, A. R., Celi, F. S., Cooper, D. S., Kim, B. W., Peeters, R. P., Rosenthal, M. S., et al. (2014) · Thyroid® · doi:10.1089/thy.2014.0028 · Cited by 1,928
“Not only is serum TSH an unreliable indicator, but it may also become undetectable with small increments in LT4 that still leave the serum FT4 in the hypothyroid range (393).”
InfluentialHormonal Replacement in Hypopituitarism in Adults: An Endocrine Society Clinical Practice Guideline
Fleseriu, M., Hashim, I. A., Karavitaki, N., Melmed, S., Murad, M. H., Salvatori, R., & Samuels, M. H. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-2118 · Cited by 945
Schneider, H. J., Aimaretti, G., Kreitschmann-Andermahr, I., Stalla, G.-K., & Ghigo, E. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60673-4 · Cited by 336
Central Hypothyroidism: Pathogenic, Diagnostic, and Therapeutic Challenges
Persani, L. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-1616 · Cited by 295
Self-citationHigham, C. E., Johannsson, G., & Shalet, S. M. (2016) · The Lancet · doi:10.1016/s0140-6736(16)30053-8 · Cited by 267
Treatment with thyroid hormone
Biondi, B., & Wartofsky, L. (2014) · Endocrine Reviews · doi:10.1210/er.2013-1083 · Cited by 259
Sklar, C. A., Antal, Z., Chemaitilly, W., Cohen, L. E., Follin, C., Meacham, L. R., & Murad, M. H. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-01175 · Cited by 224
Persani, L., Brabant, G., Dattani, M., Bonomi, M., Feldt-Rasmussen, U., Fliers, E., Gruters, A., Maiter, D., Schoenmakers, N., & van Trotsenburg, A. S. P. (2018) · European Thyroid Journal · doi:10.1159/000491388 · Cited by 222
Self-citationPituitary Dysfunction After Traumatic Brain Injury: A Clinical and Pathophysiological Approach
Tanriverdi, F., Schneider, H. J., Aimaretti, G., Masel, B. E., Casanueva, F. F., & Kelestimur, F. (2015) · Endocrine Reviews · doi:10.1210/er.2014-1065 · Cited by 218
Mazziotti, G., Frara, S., & Giustina, A. (2018) · Endocrine Reviews · doi:10.1210/er.2018-00005 · Cited by 181
Thyroid Hormone Replacement Therapy
Wiersinga, W. M. (2001) · Hormone Research in Paediatrics · doi:10.1159/000048140 · Cited by 148
Late endocrine effects of childhood cancer
Rose, S. R., Horne, V. E., Howell, J. C., Lawson, S. A., Rutter, M. M., Trotman, G. E., & Corathers, S. D. (2016) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2016.45 · Cited by 168
Endocrine Late Effects in Childhood Cancer Survivors
Chemaitilly, W., Cohen, L. E., Mostoufi‐Moab, S., Patterson, B. C., Simmons, J. H., Meacham, L. R., van Santen, H. M., & Sklar, C. A. (2018) · Journal of Clinical Oncology · doi:10.1200/jco.2017.76.3268 · Cited by 149
Central hypothyroidism — a neglected thyroid disorder
Beck-Peccoz, P., Rodari, G., Giavoli, C., & Lania, A. (2017) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2017.47 · Cited by 140
Self-citationAlexopoulou, O., Beguin, C., De Nayer, P., & Maiter, D. (2004) · European Journal of Endocrinology · doi:10.1530/eje.0.1500001 · Cited by 135
Recent advances in central congenital hypothyroidism
Schoenmakers, N., Alatzoglou, K. S., Chatterjee, V. K., & Dattani, M. T. (2015) · Journal of Endocrinology · doi:10.1530/joe-15-0341 · Cited by 125
Changes in pituitary function with ageing and implications for patient care
Veldhuis, J. D. (2013) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2013.38 · Cited by 124
Porretti, S., Giavoli, C., Ronchi, C. L., Lombardi, G., Zaccaria, M., Valle, D., Arosio, M., & Beck‐Peccoz, P. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.87.5.2042 · Cited by 112
Self-citationMechanisms related to the pathophysiology and management of central hypothyroidism
Yamada, M., & Mori, M. (2008) · Nature Clinical Practice Endocrinology & Metabolism · doi:10.1038/ncpendmet0995 · Cited by 114
“When the basal level of serum TSH is normal in patients with CH, concentrations may decrease to very low values after treatment”
BackgroundSlawik, M., Klawitter, B., Meiser, E., Schories, M., Zwermann, O., Borm, K., Peper, M., Lubrich, B., Hug, M. J., Nauck, M., et al. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-0297 · Cited by 113
Minniti, G. C., Esposito, V., Piccirilli, M., Fratticci, A., Santoro, A., & Jaffrain‐Rea, M. (2005) · European Journal of Endocrinology · doi:10.1530/eje.1.02030 · Cited by 105
Self-citationLania, A., Persani, L., & Beck-Peccoz, P. (2008) · Pituitary · doi:10.1007/s11102-008-0122-6 · Cited by 85
Self-citationRadiation-induced hypopituitarism
Fernandez, A., Brada, M., Zabuliene, L., Karavitaki, N., & Wass, J. A. H. (2009) · Endocrine-Related Cancer · doi:10.1677/erc-08-0231 · Cited by 84
Syndromes of hormone resistance in the hypothalamic–pituitary–thyroid axis
Beck-Peccoz, P., Persani, L., Calebiro, D., Bonomi, M., Mannavola, D., & Campi, I. (2006) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2006.11.001 · Cited by 83
Self-citationPortes, E. S., Oliveira, J. H. A., Maccagnan, P., & Abucham, J. (2000) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2000.01071.x · Cited by 81
Koulouri, O., Auldin, M. A., Agarwal, R., Kieffer, V., Robertson, C., Falconer Smith, J., Levy, M. J., & Howlett, T. A. (2011) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2011.03984.x · Cited by 75
Shimon, I., Cohen, O., Lubetsky, A., & Olchovsky, D. (2002) · Thyroid · doi:10.1089/105072502760339406 · Cited by 72
Bonomi, M. (2001) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.86.4.1600 · Cited by 71
Self-citationGupta, V., & Lee, M. (2011) · Indian Journal of Endocrinology and Metabolism · doi:10.4103/2230-8210.83337 · Cited by 71
Diagnosis and Treatment of Hypopituitarism: An Update
van Aken, M. O., & Lamberts, S. W. J. (2005) · Pituitary · doi:10.1007/s11102-006-6039-z · Cited by 71
Circulating Thyrotropin Bioactivity in Sporadic Central Hypothyroidism
Persani, L. (2000) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.85.10.3631 · Cited by 70
“The period of l-T4 therapy discontinuation was sufficient to induce clinical and biochemical hypothyroidism [free T4 (FT4) levels were low in all patients; see Results] and to restore levels of measurable TSH from the undetectable TSH concentrations observed during substitutive l-T4 therapy ( 19 ).”
BackgroundSelf-citationThe diagnosis and management of central hypothyroidism in 2018
Persani, L., Cangiano, B., & Bonomi, M. (2019) · Endocrine Connections · doi:10.1530/ec-18-0515 · Cited by 64
Self-citationGiavoli, C., Porretti, S., Ferrante, E., Cappiello, V., Ronchi, C. L., Travaglini, P., Epaminonda, P., Arosio, M., & Beck‐Peccoz, P. (2003) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2003.01892.x · Cited by 60
Self-citationCranial irradiation and central hypothyroidism
Rose, S. R. (2001) · Trends in Endocrinology & Metabolism · doi:10.1016/s1043-2760(00)00359-3 · Cited by 55
Behan, L. A., Monson, J. P., & Agha, A. (2011) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2010.03815.x · Cited by 53
Klose, M., Marina, D., Hartoft-Nielsen, M.-L., Klefter, O., Gavan, V., Hilsted, L., Rasmussen, Å. K., & Feldt-Rasmussen, U. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-1610 · Cited by 53
de Carvalho, G. A., Paz-Filho, G., Mesa Junior, C., & Graf, H. (2018) · European Journal of Endocrinology · doi:10.1530/eje-17-0947 · Cited by 40
Filipsson, H., & Johannsson, G. (2009) · European Journal of Endocrinology · doi:10.1530/eje-09-0319 · Cited by 50
Mazziotti, G., Mormando, M., Cristiano, A., Bianchi, A., Porcelli, T., Giampietro, A., Maffezzoni, F., Serra, V, De Marinis, L., & Giustina, A. (2014) · European Journal of Endocrinology · doi:10.1530/eje-14-0097 · Cited by 48
Thyrotropin-releasing hormone stimulation test in patients with pituitary pathology
Hartoft-Nielsen, M.-L., Lange, M., Rasmussen, Å. K., Scherer, S., Zimmermann-Belsing, T., & Feldt-Rasmussen, U. (2004) · Hormone Research in Paediatrics · doi:10.1159/000075239 · Cited by 47
Martins, M. R. A., Doin, F. L. C., Komatsu, W. R., Barros-Neto, T. L., Moisés, V. A., & Abucham, J. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-0941 · Cited by 45
Hypothalamic pituitary dysfunction amongst nasopharyngeal cancer survivors
Ratnasingam, J., Karim, N., Paramasivam, S. S., Ibrahim, L. A. A., Lim, L., Tan, A. T. B., Vethakkan, S. R., Jalaludin, A., & Chan, S. P. (2014) · Pituitary · doi:10.1007/s11102-014-0593-6 · Cited by 43
Javed, Z., Qamar, U., & Sathyapalan, T. (2015) · Indian Journal of Endocrinology and Metabolism · doi:10.4103/2230-8210.167561 · Cited by 43
Congenital Isolated Central Hypothyroidism Caused by a "Hot Spot" Mutation in the Thyrotropin-β Gene
McDermott, M. T., Haugen, B. R., Black, J. N., Wood, W. M., Gordon, D. F., & Ridgway, E. C. (2002) · Thyroid · doi:10.1089/105072502321085252 · Cited by 39
Domené, H. M., Gruñeiro-Papendieck, L., Chiesa, A., Iorcansky, S., Herzovich, V. C., Papazian, R., Forclaz, V., Prieto, L., Sansó, G., Scaglia, P., et al. (2004) · Hormone Research in Paediatrics · doi:10.1159/000075196 · Cited by 33
Central hypothyroidism in adults: better understanding for better care
Grunenwald, S., & Caron, P. (2015) · Pituitary · doi:10.1007/s11102-014-0559-8 · Cited by 35
“In practice, levothyroxine over-treatment (increased concentration of serum-soluble interleukin-2 receptor, increased Sex Hormone-Binding Globulin, hypocholesterolemia) rather than under-treatment [44] may be diagnosed by the longitudinal evaluation of such indexes of the peripheral activity of thyroid hormones.”
BackgroundResultInfluentialIsolated anterior pituitary dysfunction in adulthood
Prencipe, N., Marinelli, L., Varaldo, E., Cuboni, D., Berton, A. M., Bioletto, F., Bona, C., Gasco, V., & Grottoli, S. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1100007 · Cited by 32
Substitution von Schilddrüsenhormonen
Gärtner, R., & Reincke, M. (2008) · Der Internist · doi:10.1007/s00108-008-2109-9 · Cited by 32
Garmes, H. M., Boguszewski, C. L., Miranda, P. A. C., Martins, M. R. A., Correa‐Silva, S. R., Abucham, J., Musolino, N. R. D. C., Vilar, L., Portari, L. H. C., Gadelha, M. R., et al. (2021) · Archives of Endocrinology and Metabolism · doi:10.20945/2359-3997000000335 · Cited by 31
Yamakita, N. (2001) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.86.3.1054 · Cited by 32
Doin, F. C., Rosa-Borges, M., Martins, M. R. A., Moisés, V. A., & Abucham, J. (2012) · European Journal of Endocrinology · doi:10.1530/eje-11-0907 · Cited by 30
Curtò, L., & Trimarchi, F. (2016) · Journal of Endocrinological Investigation · doi:10.1007/s40618-016-0487-8 · Cited by 30
Karamouzis, I., Pagano, L., Prodam, F., Mele, C., Zavattaro, M., Busti, A., Marzullo, P., & Aimaretti, G. (2015) · Endocrine · doi:10.1007/s12020-015-0796-2 · Cited by 28
Rifampin-Induced Hypothyroidism in Patients with Hashimoto's Thyroiditis
Takasu, N., Takara, M., & Komiya, I. (2005) · New England Journal of Medicine · doi:10.1056/nejm200502033520524 · Cited by 27
Improved diagnosis of mild hypothyroidism using time-of-day normal ranges for thyrotropin
Rose, S. R. (2010) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2010.04.047 · Cited by 27
Optimal Free Thyroxine Levels for Thyroid Hormone Replacement in Hypothyroidism
Iverson, J. F., & Mariash, C. N. (2008) · Endocrine Practice · doi:10.4158/ep.14.5.550 · Cited by 27
Resistance to Thyroid Hormone in Hashimoto's Thyroiditis
Fukata, S., Brent, G. A., & Sugawara, M. (2005) · New England Journal of Medicine · doi:10.1056/nejm200502033520523 · Cited by 27
Endocrinopathies in Childhood Cancer Survivors
Rose, S. R. (2003) · The Endocrinologist · doi:10.1097/01.ten.0000098611.49230.10 · Cited by 27
Zwimpfer, C. (2009) · Swiss Medical Weekly · doi:10.4414/smw.2009.12654 · Cited by 26
Disorders of thyrotropin synthesis, secretion, and function
Rose, S. R. (2000) · Current Opinion in Pediatrics · doi:10.1097/00008480-200008000-00017 · Cited by 26
Hypopituitarism in the Elderly: Multifaceted Clinical and Biochemical Presentation
Foppiani, L., Ruelle, A., Bandelloni, R., Quilici, P., & Monte, P. D. (2008) · Current Aging Science · doi:10.2174/1874609810801010042 · Cited by 25
Medical Management of Hypopituitarism in Patients with Pituitary Adenomas
Arafah, B. M. (2002) · Pituitary · doi:10.1023/a:1022316631809 · Cited by 25
Treatment of central hypothyroidism*: Commentary
Beck-Peccoz, P. (2011) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2011.04037.x · Cited by 23
Self-citationTerapia de reposição hormonal no hipopituitarismo
Abucham, J., Vieira, T. C., Barbosa, E. R., Ribeiro, R. S., & Martins, M. R. A. (2003) · Arquivos Brasileiros de Endocrinologia & Metabologia · doi:10.1590/s0004-27302003000400021 · Cited by 23
Endocrine Outcomes After Pituitary Surgery
Buttan, A. K., & Mamelak, A. N. (2019) · Neurosurgery Clinics of North America · doi:10.1016/j.nec.2019.05.009 · Cited by 23
Attilakos, A., Garoufi, A., Voudris, K. A., Mastroyianni, S. D., Fotinou, A., Papadimitriou, D. T., Gavalakis, N., Prassouli, A., & Katsarou, E. (2007) · European Journal of Paediatric Neurology · doi:10.1016/j.ejpn.2007.03.002 · Cited by 23
Thyrotrophic status in patients with pituitary stalk interruption syndrome
Zhang, Q., Zang, L., Li, Y., Han, B., Gu, W., Yan, W., Jin, N., Chen, K., Du, J., Wang, X., et al. (2018) · Medicine · doi:10.1097/md.0000000000009084 · Cited by 21
Focus on GH deficiency and thyroid function
Giavoli, C., Profka, E., Rodari, G., Lania, A. G., & Beck-Peccoz, P. (2017) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2017.02.003 · Cited by 21
Self-citationDiagnosing unsuspected hypopituitarism in adults from suggestive thyroid function test results
Preiss, D., Todd, L. M., & Panarelli, M. (2008) · Annals of Clinical Biochemistry International Journal of Laboratory Medicine · doi:10.1258/acb.2007.007100 · Cited by 20
The metabolic consequences of thyroxine replacement in adult hypopituitary patients
Filipsson Nyström, H., Feldt-Rasmussen, U., Kourides, I., Popovic, V., Koltowska-Häggström, M., Jonsson, B., & Johannsson, G. (2012) · Pituitary · doi:10.1007/s11102-011-0356-6 · Cited by 18
Sesmilo, G., Simó, O., Choque, L., Casamitjana, R., Puig-Domingo, M., & Halperin, I. (2011) · Endocrinología y Nutrición · doi:10.1016/j.endonu.2010.09.006 · Cited by 18
Anterior pituitary hormone replacement therapy—a clinical review
Auernhammer, C. J., & Vlotides, G. (2007) · Pituitary · doi:10.1007/s11102-007-0001-6 · Cited by 17
Glynn, N., Halsall, D. J., Boran, G. P., Cook, P. R., McDermott, J. H., Smith, D., Tormey, W. P., Thompson, C. J., O’Gorman, D. J., McKenna, M. J., et al. (2021) · Growth Hormone & IGF Research · doi:10.1016/j.ghir.2021.101393 · Cited by 16
Early and late endocrine effects in pediatric central nervous system diseases
Aslan, I. R., & Cheung, C. C. (2014) · Journal of Pediatric Rehabilitation Medicine · doi:10.3233/prm-140299 · Cited by 16
Leptin response to endogenous acute stress is independent of pituitary function
Schafroth, U., Godang, K., Ueland, T., & Bollerslev, J. (2001) · European Journal of Endocrinology · doi:10.1530/eje.0.1450295 · Cited by 16
Hirata, Y., Fukuoka, H., Iguchi, G., Iwahashi, Y., Fujita, Y., Hari, Y., Iga, M., Nakajima, S., Nishimoto, Y., Mukai, M., et al. (2015) · European Journal of Endocrinology · doi:10.1530/eje-15-0130 · Cited by 14
Sesmilo, G., Halperin, I., & Puig-Domingo, M. (2007) · HORMONES · doi:10.14310/horm.2002.1111013 · Cited by 14
Influence of thyroxine on serum soluble interleukin-2 receptor alpha levels in thyroid disorders
Żwirska-Korczala, K., Berdowska, A., Jochem, J., Sitkiewicz, A., Birkner, E., Polaniak, R., Jędrzejowska–Szypułka, H., & Korzonek-Szlacheta, I. (2004) · Journal of Clinical Pharmacy and Therapeutics · doi:10.1111/j.1365-2710.2004.00547.x · Cited by 14
Carmichael, J. D. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-804169-7.00010-6 · Cited by 14
Problems in the Management of Hypothyroidism
Ladenson, P. W. (2003) · Humana Press eBooks · doi:10.1007/978-1-59259-352-1_8 · Cited by 13
Central hypothyroidism improves with age in very young children with Prader‐Willi syndrome
Konishi, A., Ida, S., Shoji, Y., Etani, Y., & Kawai, M. (2020) · Clinical Endocrinology · doi:10.1111/cen.14323 · Cited by 12
Woodmansee, W. W. (2013) · Wiley eBooks · doi:10.1002/9781118559406.ch16 · Cited by 10
Pantalone, K. M., Hatipoğlu, B., Gupta, M. K., Kennedy, L., & Hamrahian, A. H. (2015) · Case Reports in Endocrinology · doi:10.1155/2015/965191 · Cited by 10
A Novel IGSF1 Mutation in a Boy With Short Stature and Hypercholesterolemia: A Case Report
Heinen, C. A., Zwaveling‐Soonawala, N., Fliers, E., Turgeon, M., Bernard, D. J., & van Trotsenburg, A. S. P. (2017) · Journal of the Endocrine Society · doi:10.1210/js.2017-00107 · Cited by 10
A Case Series of Patients With Central Hypothyroidism From Oxcarbazepine Therapy
Schweiger, B. M., Lao, A.-J., & Tavyev, J. (2020) · Journal of Child Neurology · doi:10.1177/0883073820962926 · Cited by 8
Carmichael, J. D. (2010) · Elsevier eBooks · doi:10.1016/b978-0-12-380926-1.10010-0 · Cited by 8
Gudmundsdottir, A., & Schlechte, J. (2002) · The Endocrinologist · doi:10.1097/00019616-200205000-00009 · Cited by 8
Neuroendocrine Complications of Cancer Therapy
Leung, W. H., Rose, S. R., & Merchant, T. E. (2005) · Springer eBooks · doi:10.1007/3-540-26498-1_5 · Cited by 8
Torremante, P., Flock, F., & Kirschner, W. (2011) · Journal of Thyroid Research · doi:10.4061/2011/905734 · Cited by 7
Tratamiento del hipotiroidismo
Arnao, M. D. R., Sánchez, A. R., Cabarcos, A. P., & Arnao, J. R. (2002) · Anales de Pediatría · Cited by 7
Monitorización del tratamiento con tiroxina en el hipotiroidismo primario y central
Sesmilo, G. (2005) · Endocrinología y Nutrición · doi:10.1016/s1575-0922(05)71032-9 · Cited by 7
Castets, S., Albarel, F., Bachelot, A., Brun, G., Bouligand, J., Briet, C., Quoc, E. B., Cazabat, L., Chabbert‐Buffet, N., Christin‐Maître, S., et al. (2024) · Annales d Endocrinologie · doi:10.1016/j.ando.2024.03.001 · Cited by 6
Patterns of pituitary dysfunction three months or more after traumatic brain injury
Alibrahim, N. T. Y., Al-Khaqani, F., & Mansour, A. A. (2018) · Avicenna Journal of Medicine · doi:10.4103/ajm.ajm_2_18 · Cited by 6
Metabolic and Endocrine Challenges
Martucci, G., Bonicolini, E., Parekh, D., Thein, O. S., Scherkl, M., & Amrein, K. (2020) · Seminars in Respiratory and Critical Care Medicine · doi:10.1055/s-0040-1713084 · Cited by 6
Varlamov, E. V., & Fleseriu, M. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-99899-4.00019-6 · Cited by 6
Wheeler, E., Choy, K. W., Chin, L. K., Wijeratne, N. G., McNeil, A. R., Yen, T., Matthews, S. J., Deam, D. R., Lu, Z. X., Loh, T. P., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-55690-x · Cited by 6
Treating Hypopituitarism in the Over 65s: Review of Clinical Studies
Paragliola, R. M., Locantore, P., Corsello, S. M., & Salvatori, R. (2023) · Clinical Interventions in Aging · doi:10.2147/cia.s370782 · Cited by 6
Subclinical central hypothyroidism in patients with hypothalamic-pituitary disease: does it exist?
Abucham, J., & Martins, M. R. A. (2024) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-024-09876-y · Cited by 5
Uncertainties in endocrine substitution therapy for central endocrine insufficiencies
Persani, L., & Bonomi, M. (2014) · Handbook of clinical neurology · doi:10.1016/b978-0-444-59602-4.00027-7 · Cited by 5
Self-citationDiagnosing and treating the elderly individual with hypopituitarism
Corsello, A., Paragliola, R. M., & Salvatori, R. (2023) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-023-09870-w · Cited by 5
Metadata
- Authors
- Ferretti, E., Persani, L., Jaffrain-Rea, M.-L., Giambona, S., Tamburrano, G., & Beck-Peccoz, P.
- Affiliations
- University of L'Aquila (IT)
- University of Milan (IT)
- the Department of Experimental Medicine (E. F., M.-L.J.-R.), University of L’Aquila, L’Aquila, Italy
- Sapienza University of Rome (IT)
- Institute of Endocrine Sciences (L.P., S.G., P.B.-P.), University of Milan, Ospedale Maggiore IRCCS, Istituto Auxologico Italiano IRCCS, and Istituto Clinico Humanitas, Milan
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 1999-03-01
- Volume
- 84
- Issue
- 3
- Pages
- 924-929
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2096057448
- Cited by
- 134
- References
- 34
- Citations by year
- 2025: 2 · 2024: 2 · 2023: 3 · 2022: 3 · 2021: 4 · 2020: 4 · 2019: 6 · 2018: 7 · 2017: 5 · 2016: 6 · 2015: 8 · 2014: 9 · 2013: 6 · 2012: 7
- FWCI
- 3.23
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- IRIS Research product catalog (Sapienza University of Rome) (submittedVersion)
- Funders
- Johnson and Johnson
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Thyroid Disorders and Treatments
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pituitary Gland Disorders and Treatments
- Keywords
- central hypothyroidism, levothyroxine replacement therapy, treatment adequacy, free thyroxine, free triiodothyronine, thyroid-stimulating hormone, thyroid hormone action, soluble interleukin-2 receptor, overtreatment, undertreatment, dose adjustment
- MeSH terms
- Adult, Evaluation Studies as Topic, Female, Humans, Hypothyroidism, Male, Middle Aged, Prospective Studies, Thyroid Hormones, Thyroxine, Hormone Replacement Therapy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.